SOMATOFLEX 10IU™ [somatropin [rDNA origin] for injection is a recombinant DNA-derived polypeptide hormone. It has 191 amino acid profile and a molecular weight of 22,125 daltons, with an amino acid sequence identical to human pituitary-derived growth hormone [somatropin].

The product is synthesized in a modified Escherichia coli strain that has been engineered to express the human growth hormone gene. SOMATOFLEX 10IU™ is a sterile, white lyophilized or freeze-dried powder intended for subcutaneous administration when mixed with a suitable diluent.

Viktropin’s lyophilised recombinant human growth hormone, often referred to as rHGH or simply growth hormone, is a highly specialized and technologically advanced form of this critical hormone. Derived through complex recombinant DNA techniques, this synthetic version of the natural human growth hormone is identical in structure to the endogenous form produced by the pituitary gland. Consisting of 191 amino acids, this lyophilized preparation is carefully engineered to maintain the full biological activity and potency of the original growth hormone molecule.

The lyophilization process removes all water content, leaving behind a stable, powdered form that can be easily reconstituted and administered through injection. This innovative delivery method protects the delicate hormone structure, ensuring it remains fully intact and ready to exert its profound effects on the human body. Recombinant growth hormone plays a vital role in regulating processes like tissue repair, muscle growth, bone density and metabolism.

Viktropin’s lyophilized formulation allows for precise dosing, extended shelf life, convenient transport and storage compared to the aqueous hormone presentation. These cutting-edge biotechnology product represents a major advancement in growth hormone therapy, providing patients and clinicians with a reliable, high-quality source of this critical endocrine compound.